Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | KIF11 | P52732 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.39 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.39 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4268940 | 0.89 | TSHR (0.48) | TSHRLMNATYRALDH1A1SMN1; SMN2 | |
| SCHEMBL11214660 | 0.89 | TSHR (0.48) | TSHRLMNATYRALDH1A1SMN1; SMN2 | |
| SCHEMBL19540477 | 0.88 | TSHR (0.42) | TSHRLMNATYRALDH1A1SMN1; SMN2 | |
| SCHEMBL11388046 | 0.85 | TSHR (0.44) | TSHRLMNATYRALDH1A1SMN1; SMN2 | |
| SCHEMBL25450061 | 0.84 | CYP2D6 (0.41) | TSHRLMNATYRALDH1A1SMN1; SMN2 | |
| SCHEMBL2271509 | 0.82 | TSHR (0.52) | TSHRLMNATYRALDH1A1SMN1; SMN2 | |
| SCHEMBL25449464 | 0.81 | ALDH1A1 (0.40) | TSHRLMNATYRALDH1A1SMN1; SMN2 | |
| SCHEMBL424728 | 0.80 | TSHR (0.73) | TSHRLMNATYRALDH1A1KIF11 | |
| SCHEMBL10013103 | 0.80 | TSHR (0.50) | TSHRLMNATYRALDH1A1SMN1; SMN2 | |
| SCHEMBL799910 | 0.80 | EPHX2 (0.53) | TSHRLMNATYRALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0278257-B1 | 4-TERT.-BUTYL-1,2-BENZENEDITHIOL, COMPLEX COMPOUNDS DERIVED THEREFROM, AND A METHOD OF PRODUCING THE SAME | SEITETSU KAGAKU CO., LTD. (JP) | 1992-05-13 | — | — | EP | claimed |
| EP-0278257-A1 | 4-Tert.-butyl-1,2-benzenedithiol, complex compounds derived therefrom, and a method of producing the same | SEITETSU KAGAKU CO., LTD. (JP) | 1988-08-17 | — | — | EP | claimed |
| JP-1125386-A | — | — | None | — | — | JP | disclosed |
| JP-63307853-A | — | — | None | — | — | JP | disclosed |
| US-12600837-B2 | Rubber composition and crosslinked rubber molded product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-04-14 | — | — | US | disclosed |
| EP-4527473-B1 | GOLF BALL | SUMITOMO RUBBER IND (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-12544628-B2 | Golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-02-10 | — | — | US | disclosed |
| US-20260027422-A1 | GOLF BALL | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-01-29 | — | — | US | disclosed |
| US-20250269241-A1 | GOLF BALL | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2025-08-28 | — | — | US | disclosed |
| US-12357881-B2 | Golf ball | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2025-07-15 | — | — | US | disclosed |
| EP-4286020-B1 | GOLF BALL | SUMITOMO RUBBER IND (JP) | 2025-07-02 | — | — | EP | disclosed |
| JP-S63307853-A | NOVEL 4-TERTIARY BUTYL-1,2-BENZENEDITHIOL, NICKEL COMPLEX THEREOF AND PRODUCTION THEREOF | SEITETSU KAGAKU CO LTD | 1988-12-15 | — | — | JP | disclosed |
| EP-0278257-A1 | 4-Tert.-butyl-1,2-benzenedithiol, complex compounds derived therefrom, and a method of producing the same | SEITETSU KAGAKU CO., LTD. (JP) | 1988-08-17 | — | — | EP | disclosed |
| EP-0278257-A1 | 4-Tert.-butyl-1,2-benzenedithiol, complex compounds derived therefrom, and a method of producing the same | SEITETSU KAGAKU CO., LTD. (JP) | 1988-08-17 | — | — | EP | disclosed |
| EP-0043788-B1 | IMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-10-30 | — | — | EP | disclosed |
| EP-0038459-B1 | PROCESS FOR THE PREVENTION OF REVERSION DURING THE MANUFACTURE OF RUBBER VULCANISATES | BAYER AG (DE) | 1985-07-10 | — | — | EP | disclosed |
| US-4528298-A | Antiinflammatory imidazole derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-07-09 | — | — | US | disclosed |
| US-4402960-A | Antiinflammatory imidazole derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1983-09-06 | — | — | US | disclosed |
| US-4340695-A | Vulcanization system, rubber mixture containing said system and a process of vulcanization | BAYER AKTIENGESELLSCHAFT (DE) | 1982-07-20 | — | — | US | disclosed |
| US-4303765-A | PEPTIZATION WITH AROMATIC POLYSULFIDE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027422-A1 | GOLF BALL | KIF5A, KIF5C, SURF4 | TSHR 1398/4885LMNA 2773/4885TYR 4020/4885 |
| US-12544628-B2 | Golf ball | KIF5A, KIF5C, SURF4 | TSHR 1538/4885LMNA 2851/4885TYR 3783/4885 |
| US-12600837-B2 | Rubber composition and crosslinked rubber molded product | RER1, RIF1, SHC1 | TSHR 2922/4885LMNA 2803/4885TYR 3442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.